Enovis (ENOV) Capital Expenditures (2010 - 2026)
Enovis' (ENOV) quarterly Capital Expenditures came in at $52.8 million in Q2 2026, up 22.06% year-on-year from $43.3 million in Q2 2025, and down 6.13% on a QoQ basis from $56.3 million in Q4 2025.
Enovis (ENOV) Capital Expenditures (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Capital Expenditures data on file, last reported at $52.8 million in Q2 2026.
- On a quarterly basis, Capital Expenditures rose 22.06% year-over-year to $52.8 million in Q2 2026; TTM through Apr 2026 was $206.9 million, a 10.62% increase from a year earlier, with the FY2025 full-year figure at $197.4 million, up 9.22% from the prior year.
- Capital Expenditures for Q2 2026 stood at $52.8 million, down from $56.3 million in the prior quarter.
- Over the last five years, Capital Expenditures for ENOV reached as high as $56.3 million in Q4 2025 and fell as low as $20.9 million in Q3 2022.
- Historically, Capital Expenditures has averaged $38.7 million across 5 years, with a median of $36.9 million in 2024.
- Across the five-year window, Capital Expenditures retreated 27.91% in 2022 and surged 90.35% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $36.8 million in 2022, then fell by 24.03% to $27.9 million in 2023, then jumped by 90.35% to $53.2 million in 2024, then advanced by 5.76% to $56.3 million in 2025, then retreated by 6.13% to $52.8 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $52.8 million in Q2 2026, $56.3 million in Q4 2025, and $53.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 52.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 52.80 Mn |
| Apr 3, 2026 | 52.80 Mn |
| Dec 31, 2025 | 56.25 Mn |
| Dec 31, 2025 | 56.25 Mn |
| Oct 3, 2025 | 53.49 Mn |
| Oct 3, 2025 | 53.49 Mn |
| Jul 4, 2025 | 44.37 Mn |
| Jul 4, 2025 | 44.37 Mn |
| Apr 4, 2025 | 43.26 Mn |
| Apr 4, 2025 | 43.26 Mn |
| Dec 31, 2024 | 53.19 Mn |
| Dec 31, 2024 | 53.19 Mn |
| Sep 27, 2024 | 51.19 Mn |
| Sep 27, 2024 | 51.19 Mn |
| Jun 28, 2024 | 39.41 Mn |
| Jun 28, 2024 | 39.41 Mn |
| Mar 29, 2024 | 36.93 Mn |
| Mar 29, 2024 | 36.93 Mn |
| Dec 31, 2023 | 27.94 Mn |
| Dec 31, 2023 | 27.94 Mn |